Seattle, Washington, Feb. 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing PotBotics Inc., a leading data aggregation and technology company in the global medical cannabis market. The company launched an innovative new vaporizer in December designed specifically for medical cannabis users. Investors may want to take a closer look at vaporizer trends and the company’s innovative approach as it looks to go public over the near-term.
CFN Media recently sat down with PotBotics Co-founder and CEO David Goldstein to demonstrate the company’s innovative new vaporizer product, RYAH:
Please click here to see PotBotics CEO Video
Growing Market for Vaporizers
The global e-cigarette and vaporizer market is projected to grow at a 20.8 percent compound annual growth rate to $61.4 billion by 2025, according to Research and Markets, which notes that the cannabis industry is a major source of growth in the industry. While the recreational cannabis industry represents a large potential market, vaporizers could be most impactful in the medical cannabis market where patients need alternatives to smoking.
Most medical users still smoke cannabis as their primary delivery method. After all, igniting buds is the simplest way to reach temperatures needed to release cannabinoids. The problem is that smoke inhalation delivers damaging carcinogens and other materials through the bronchial tree and into the lungs. Long-term exposure to these chemicals in the lungs can lead to a range of medical conditions, including COPD and lung cancer. Ignition methods can also be very inconsistent, which makes it hard to achieve predictable results.
Vaporizers are an increasingly popular alternative with fewer, if any, negative side-effects. Instead of burning buds and producing smoke, vaporizers dehydrate buds in a way that releases cannabinoids without ever catching fire. No carcinogens or other harmful chemicals ever enter the lungs, but users still benefit from the greater bioavailability of smoking versus other consumption methods that are subject to metabolism by the liver.
Please Click Here to see an Investor Presentation
RYAH Ensures Predictable Results
Medical cannabis enjoys widespread support among doctors. In fact, a 2013 survey found that more than three-quarters of doctors would approve the use of medical marijuana. The problem is that there are few standardized delivery methods that guarantee dosages and measure the effects of cannabinoids in individual patients. In other words, it’s much harder for a doctor to tell a patient to go to a dispensary than for them to write a prescription.
PotBotics, a leading data aggregation and technology company in the global medical cannabis market, aims to change those dynamics with its new dose-measuring vaporizer. RYAH is the first vaporizer that lets users track and control a wide range of variables—including inhalation amount and temperatures—to ensure consistent and predictable results when used with its medical-grade oil or dry herb capsules.
The company’s companion app lets consumers easily set their dosing parameters and track what medicine works best for them. In addition, the data can be shared with physicians and compiled into meaningful data sets to analyze efficacy. The company’s long-term goal is to advance the understanding of cannabinoids to a point where they can predict patient outcomes by measuring both individual experiences and medical literature.
“Consumers have picked up the micro-dosing trends, but unknowingly, have also accepted a lack of transparency for their medical regimen,” says PotBotics CEO David Goldstein. “RYAH is here to break that mold. We are very pleased to bring state-of-the-art technology to complement our existing suite of products in order to further understand and predict patient outcomes.”
Looking Ahead
PotBotics Inc. has developed an innovative vaporizer that cuts through the oversaturated market to help medical cannabis patients improve their experience. With the market projected to reach $60 billion by 2025, investors may want to take a closer look at the company as it rolls out RYAH, advances its data-driven products, and looks to go public over the near-term.
For more information, visit the company’s website at www.potbotics.com.
Please Click Here to see an Investor Presentation
Please click here to see PotBotics CEO Video
Please follow the link to read the full article:
https://www.cannabisfn.com/potbotics-takes-aim-at-the-vaporizer-market-with-ryah/
About CFN Media
CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.
Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany
Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com
Disclaimer
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/